Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 3, 2008
Stem Cells Vol. 26 No. 9 September 2008, pp. 2257 -2265
doi:10.1634/stemcells.2008-0291; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2008-0291v1
2008-0291v2
26/9/2257    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braam, S. R.
Right arrow Articles by Mummery, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braam, S. R.
Right arrow Articles by Mummery, C. L.

EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS

Recombinant Vitronectin Is a Functionally Defined Substrate That Supports Human Embryonic Stem Cell Self-Renewal via {alpha}Vβ5 Integrin

Stefan R. Braama,b, Laura Zeinstraa, Sandy Litjensa, Dorien Ward-van Oostwaarda,b, Stieneke van den Brinka, Linda van Laakea,c, Franck Lebrina, Peter Katsd, Ron Hochstenbachd, Robert Passiera,b, Arnoud Sonnenberge, Christine L. Mummerya,b,c

aHubrecht Institute, Developmental Biology and Stem Cell Research, Utrecht, The Netherlands;
bDepartment of Anatomy and Embryology, Leiden University Medical Centre, Leiden, The Netherlands;
cHeart and Lung Division and
dDepartment of Biomedical Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands;
eDivision of Cell Biology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Key Words. Human embryonic stem cells • Self-renewal • Defined substrate • Integrins • Extracellular matrix

Correspondence: Correspondence: Christine Mummery, Ph.D., Leiden University Medical Centre, Postal Zone S-1-P, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Telephone: ++31-71-526 9307; Fax: ++31-71-526 8289; e-mail: c.l.mummery{at}lumc.nl

Received on April 17, 2008; accepted for publication on June 21, 2008.

First published online in STEM CELLS EXPRESS  July 3, 2008.


Defined growth conditions are essential for many applications of human embryonic stem cells (hESC). Most defined media are presently used in combination with Matrigel, a partially defined extracellular matrix (ECM) extract from mouse sarcoma. Here, we defined ECM requirements of hESC by analyzing integrin expression and ECM production and determined integrin function using blocking antibodies. hESC expressed all major ECM proteins and corresponding integrins. We then systematically replaced Matrigel with defined medium supplements and ECM proteins. Cells attached efficiently to natural human vitronectin, fibronectin, and Matrigel but poorly to laminin + entactin and collagen IV. Integrin-blocking antibodies demonstrated that {alpha}Vβ5 integrins mediated adhesion to vitronectin, {alpha}5β1 mediated adhesion to fibronectin, and {alpha}6β1 mediated adhesion to laminin + entactin. Fibronectin in feeder cell-conditioned medium partially supported growth on all natural matrices, but in defined, nonconditioned medium only Matrigel or (natural and recombinant) vitronectin was effective. Recombinant vitronectin was the only defined functional alternative to Matrigel, supporting sustained self-renewal and pluripotency in three independent hESC lines.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.